Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 145289, 8 pages
http://dx.doi.org/10.1155/2014/145289
Review Article

An Overview of the Spindle Assembly Checkpoint Status in Oral Cancer

1CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Rua Central de Gandra 1317, 4585-116 Gandra, Portugal
2Centre for Molecular and Structural Biomedicine, CBME/IBB, University of Algarve, 8005-139 Faro, Portugal
3Centro de Química Medicinal da Universidade do Porto (CEQUIMED-UP), Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal
4Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR), Universidade do Porto, Rua dos Bragas 289, 4050-123 Porto, Portugal

Received 28 February 2014; Accepted 18 May 2014; Published 3 June 2014

Academic Editor: Heide Schatten

Copyright © 2014 José Henrique Teixeira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Forastiere, W. Koch, A. Trotti, and D. Sidransky, “Head and neck cancer,” The New England Journal of Medicine, vol. 345, no. 26, pp. 1890–1900, 2001. View at Google Scholar · View at Scopus
  2. S. Warnakulasuriya, “Global epidemiology of oral and oropharyngeal cancer,” Oral Oncology, vol. 45, no. 4-5, pp. 309–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. C. Reshmi and S. M. Gollin, “Chromosomal instability in oral cancer cells,” Journal of Dental Research, vol. 84, no. 2, pp. 107–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Sato, N. Uzawa, K.-I. Takahashi, K. Myo, Y. Ohyama, and T. Amagasa, “Prognostic utility of chromosomal instability detected by fluorescence in situ hybridization in fine-needle aspirates from oral squamous cell carcinomas,” BMC Cancer, vol. 10, article 182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Diaz-Rodríguez, R. Sotillo, J.-M. Schvartzman, and R. Benezra, “Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 43, pp. 16719–16724, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Sotillo, E. Hernando, E. Díaz-Rodríguez et al., “Mad2 overexpression promotes aneuploidy and tumorigenesis in mice,” Cancer Cell, vol. 11, no. 1, pp. 9–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. B. A. A. Weaver, A. D. Silk, C. Montagna, P. Verdier-Pinard, and D. W. Cleveland, “Aneuploidy acts both oncogenically and as a tumor suppressor,” Cancer Cell, vol. 11, no. 1, pp. 25–36, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Musacchio and E. D. Salmon, “The spindle-assembly checkpoint in space and time,” Nature Reviews Molecular Cell Biology, vol. 8, no. 5, pp. 379–393, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Silva, J. Barbosa, A. V. Nascimento, J. Faria, R. Reis, and H. Bousbaa, “Monitoring the fidelity of mitotic chromosome segregation by the spindle assembly checkpoint,” Cell Proliferation, vol. 44, no. 5, pp. 391–400, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Tanaka, M. Tanaka, and T. Tanaka, “Oral carcinogenesis and oral cancer chemoprevention: a review,” Pathology Research International, vol. 2011, Article ID 431246, 10 pages, 2011. View at Publisher · View at Google Scholar
  11. P. K. Tsantoulis, N. G. Kastrinakis, A. D. Tourvas, G. Laskaris, and V. G. Gorgoulis, “Advances in the biology of oral cancer,” Oral Oncology, vol. 43, no. 6, pp. 523–534, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Yan, I. I. Wistuba, M. R. Emmert-Buck, and H. S. Erickson, “Squamous cell carcinoma—similarities and differences among anatomical sites,” American Journal of Cancer Research, vol. 1, no. 3, pp. 275–300, 2011. View at Google Scholar
  13. S. M. Rothenberg and L. W. Ellisen, “The molecular pathogenesis of head and neck squamous cell carcinoma,” Journal of Clinical Investigation, vol. 122, no. 6, pp. 1951–1957, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. D. Llewellyn, N. W. Johnson, and K. A. A. S. Warnakulasuriya, “Risk factors for squamous cell carcinoma of the oral cavity in young people—a comprehensive literature review,” Oral Oncology, vol. 37, no. 5, pp. 401–418, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. C. S. Miller and D. K. White, “Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 82, no. 1, pp. 57–68, 1996. View at Google Scholar · View at Scopus
  16. P. B. Sugerman and E. J. Shillitoe, “The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship,” Oral Diseases, vol. 3, no. 3, pp. 130–147, 1997. View at Google Scholar · View at Scopus
  17. L. S. Monteiro, L. Antunes, M. J. Bento, and S. Warnakulasuriya, “Incidence rates and trends of lip, oral and oro-pharyngeal cancers in Portugal,” Journal of Oral Pathology & Medicine, vol. 42, no. 4, pp. 345–351, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. B. W. Neville and T. A. Day, “Oral cancer and precancerous lesions,” Ca: A Cancer Journal for Clinicians, vol. 52, no. 4, pp. 195–215, 2002. View at Google Scholar · View at Scopus
  19. R. Mehrotra, A. Gupta, M. Singh, and R. Ibrahim, “Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions,” Molecular Cancer, vol. 5, article 11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Patel, C. Leethanakul, and J. S. Gutkind, “New approaches to the understanding of the molecular basis of oral cancer,” Critical Reviews in Oral Biology and Medicine, vol. 12, no. 1, pp. 55–63, 2001. View at Google Scholar · View at Scopus
  21. M. N. Islam, L. Kornberg, E. Veenker, D. M. Cohen, and I. Bhattacharyya, “Anatomic site based ploidy analysis of oral premalignant lesions,” Head and Neck Pathology, vol. 4, no. 1, pp. 10–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Scully and R. Bedi, “Ethnicity and oral cancer,” The Lancet Oncology, vol. 1, no. 1, pp. 37–42, 2000. View at Google Scholar · View at Scopus
  23. L. L. Gleich and F. N. Salamone, “Molecular genetics of head and neck cancer,” Cancer Control, vol. 9, no. 5, pp. 369–378, 2002. View at Google Scholar · View at Scopus
  24. S. Humayun and V. R. Prasad, “Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: an immunohistochemical study,” National Journal of Maxillofacial Surgery, vol. 2, no. 1, pp. 38–46, 2011. View at Publisher · View at Google Scholar
  25. W. H. Liggett Jr. and D. Sidransky, “Role of the p16 tumor suppressor gene in cancer,” Journal of Clinical Oncology, vol. 16, no. 3, pp. 1197–1206, 1998. View at Google Scholar · View at Scopus
  26. H. K. Williams, “Molecular pathogenesis of oral squamous carcinoma,” Journal of Clinical Pathology: Molecular Pathology, vol. 53, no. 4, pp. 165–172, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. W. G. Yarbrough, C. Shores, D. L. Witsell, M. C. Weissler, M. E. Fidler, and T. M. Gilmer, “ras mutations and expression in head and neck squamous cell carcinomas,” Laryngoscope, vol. 104, no. 11, part 1, pp. 1337–1347, 1994. View at Google Scholar · View at Scopus
  28. A. J. Holland and D. W. Cleveland, “Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis,” Nature Reviews Molecular Cell Biology, vol. 10, no. 7, pp. 478–487, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. E. A. Foley and T. M. Kapoor, “Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore,” Nature Reviews Molecular Cell Biology, vol. 14, no. 1, pp. 25–37, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Sudakin, G. K. T. Chan, and T. J. Yen, “Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2,” The Journal of Cell Biology, vol. 154, no. 5, pp. 925–936, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. C. L. Rieder, R. W. Cole, A. Khodjakov, and G. Sluder, “The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores,” The Journal of Cell Biology, vol. 130, no. 4, pp. 941–948, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. A. de Antoni, C. G. Pearson, D. Cimini et al., “The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint,” Current Biology, vol. 15, no. 3, pp. 214–225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Yu, “Structural activation of Mad2 in the mitotic spindle checkpoint: The two-state Mad2 model versus the Mad2 template model,” The Journal of Cell Biology, vol. 173, no. 2, pp. 153–157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Luo and H. Yu, “Protein metamorphosis: the two-state behavior of Mad2,” Structure, vol. 16, no. 11, pp. 1616–1625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. J. Skinner, S. Wood, J. Shorter, S. W. Englander, and B. E. Black, “The Mad2 partial unfolding model: regulating mitosis through Mad2 conformational switching,” The Journal of Cell Biology, vol. 183, no. 5, pp. 761–768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Han, A. Holland, D. Fachinetti, A. Kulukian, B. Cetin, and D. Cleveland, “Catalytic assembly of the mitotic checkpoint inhibitor BubR1-Cdc20 by a Mad2-induced functional switch in Cdc20,” Molecular Cell, vol. 51, no. 1, pp. 92–104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. D. M. Brady and K. G. Hardwick, “Complex formation between Mad1p, Bub1p and Bub3p is crucial for spindle checkpoint function,” Current Biology, vol. 10, no. 11, pp. 675–678, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. V. L. Johnson, M. I. F. Scott, S. V. Holt, D. Hussein, and S. S. Taylor, “Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression,” Journal of Cell Science, vol. 117, part 8, pp. 1577–1589, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. Z. Tang, H. Shu, D. Oncel, S. Chen, and H. Yu, “Phosphorylation of Cdc20 by Bub1 provides a catalytic mechanism for APC/C inhibition by the spindle checkpoint,” Molecular Cell, vol. 16, no. 3, pp. 387–397, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Kang, M. Yang, B. Li et al., “Structure and substrate recruitment of the human spindle checkpoint kinase Bub1,” Molecular Cell, vol. 32, no. 3, pp. 394–405, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Abrieu, L. Magnaghi-Jaulin, J. A. Kahana et al., “Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint,” Cell, vol. 106, no. 1, pp. 83–93, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Jelluma, T. B. Dansen, T. Sliedrecht, N. P. Kwiatkowski, and G. J. P. L. Kops, “Release of Mps1 from kinetochores is crucial for timely anaphase onset,” The Journal of Cell Biology, vol. 191, no. 2, pp. 281–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. S.-T. Liu, G. K. T. Chan, J. C. Hittle, G. Fujii, E. Lees, and T. J. Yen, “Human MPS1 kinase is required for mitotic arrest induced by the loss of CENP-E from kinetochores,” Molecular Biology of the Cell, vol. 14, no. 4, pp. 1638–1651, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Vigneron, S. Prieto, C. Bernis, J.-C. Labbé, A. Castro, and T. Lorca, “Kinetochore localization of spindle checkpoint proteins: who controls whom?” Molecular Biology of the Cell, vol. 15, no. 10, pp. 4584–4596, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Ruchaud, M. Carmena, and W. C. Earnshaw, “The chromosomal passenger complex: one for all and all for one,” Cell, vol. 131, no. 2, pp. 230–231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. T. U. Tanaka, N. Rachidi, C. Janke et al., “Evidence that the Ipl1-Sli15 (Aurora Kinase-INCENP) complex promotes chromosome bi-orientation by altering kinetochore-spindle pole connections,” Cell, vol. 108, no. 3, pp. 317–329, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. K. F. DeLuca, S. M. A. Lens, and J. G. DeLuca, “Temporal changes in Hec1 phosphorylation control kinetochore—microtubule attachment stability during mitosis,” Journal of Cell Science, vol. 124, part 4, pp. 622–634, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Ditchfield, V. L. Johnson, A. Tighe et al., “Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores,” The Journal of Cell Biology, vol. 161, no. 2, pp. 267–280, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. B. J. Howell, B. F. McEwen, J. C. Canman et al., “Cytoplasmic dynein/dynactin drives kinetochore protein transport to the spindle poles and has a role in mitotic spindle checkpoint inactivation,” The Journal of Cell Biology, vol. 155, no. 7, pp. 1159–1172, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. G. J. P. L. Kops, B. A. A. Weaver, and D. W. Cleveland, “On the road to cancer: aneuploidy and the mitotic checkpoint,” Nature Reviews Cancer, vol. 5, no. 10, pp. 773–785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. G. J. P. L. Kops, D. R. Foltz, and D. W. Cleveland, “Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 23, pp. 8699–8704, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Janssen and R. H. Medema, “Mitosis as an anti-cancer target,” Oncogene, vol. 30, no. 25, pp. 2799–2809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. A.-L. Salmela and M. J. Kallio, “Mitosis as an anti-cancer drug target,” Chromosoma, vol. 122, no. 5, pp. 431–449, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. K.-S. Chan, C.-G. Koh, and H.-Y. Li, “Mitosis-targeted anti-cancer therapies: where they stand,” Cell Death and Disease, vol. 3, no. 10, article e411, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. D. A. Brito and C. L. Rieder, “Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint,” Current Biology, vol. 16, no. 12, pp. 1194–1200, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. K. E. Gascoigne and S. S. Taylor, “Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs,” Cancer Cell, vol. 14, no. 2, pp. 111–122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. S. M. Gollin, “Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease,” Head & Neck, vol. 23, no. 3, pp. 238–253, 2001. View at Google Scholar
  58. G. Mondal, S. Sengupta, C. K. Panda, S. M. Gollin, W. S. Saunders, and S. Roychoudhury, “Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer,” Carcinogenesis, vol. 28, no. 1, pp. 81–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. E. Thirthagiri, C. M. Robinson, S. Huntley et al., “Spindle assembly checkpoint and centrosome abnormalities in oral cancer,” Cancer Letters, vol. 258, no. 2, pp. 276–285, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Tanaka, Y. Mohri, M. Ohi et al., “Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy,” Clinical Oncology, vol. 20, no. 8, pp. 639–646, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. I. M. Moura, M. L. Delgado, P. M. Silva et al., “High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma,” Journal of Oral Pathology & Medicine, vol. 43, no. 3, pp. 225–231, 2014. View at Publisher · View at Google Scholar
  62. P.-C. Hsieh, Y.-K. Chen, K.-B. Tsai et al., “Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 109, no. 2, pp. 257–267, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. R. C. P. Lira, F. A. Miranda, M. C. M. Guimarães et al., “BUBR1 expression in benign oral lesions and squamous cell carcinomas: correlation with human papillomavirus,” Oncology Reports, vol. 23, no. 4, pp. 1027–1036, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Rizzardi, L. Torelli, E. Barresi et al., “BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival,” Head & Neck, vol. 33, no. 5, pp. 727–733, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Hannisdal, E. Burum-Auensen, A. Schjølberg, P. M. de Angelis, and O. P. F. Clausen, “Correlation between reduced expression of the spindle checkpoint protein BubR1 and bad prognosis in tonsillar carcinomas,” Head & Neck, vol. 32, no. 10, pp. 1354–1362, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. G. Pannone, S. A. H. Hindi, A. Santoro et al., “Aurora B expression as a prognostic indicator and possibile therapeutic target in oral squamous cell carcinoma,” International Journal of Immunopathology and Pharmacology, vol. 24, no. 1, pp. 79–88, 2011. View at Google Scholar · View at Scopus
  67. G. Qi, I. Ogawa, Y. Kudo et al., “Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer,” Virchows Archiv, vol. 450, no. 3, pp. 297–302, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. J.-H. Chen, K.-T. Yeh, Y.-M. Yang, J.-G. Chang, H.-E. Lee, and S.-Y. Hung, “High expressions of histone methylation- and phosphorylation-related proteins are associated with prognosis of oral squamous cell carcinoma in male population of Taiwan,” Medical Oncology, vol. 30, no. 2, article 513, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. W.-J. Wu, K.-S. Hu, D.-S. Wang et al., “CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer,” Journal of Translational Medicine, vol. 11, no. 1, article 142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Yamamoto, H. Matsuyama, Y. Chochi et al., “Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer,” Cancer Genetics and Cytogenetics, vol. 174, no. 1, pp. 42–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. Z.-Z. Lin, Y.-M. Jeng, F.-C. Hu et al., “Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B overexpression in HCC,” BMC Cancer, vol. 10, article 461, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. J.-M. Schvartzman, R. Sotillo, and R. Benezra, “Mitotic chromosomal instability and cancer: mouse modelling of the human disease,” Nature Reviews Cancer, vol. 10, no. 2, pp. 102–115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Kollareddy, D. Zheleva, P. Dzubak, P. S. Brahmkshatriya, M. Lepsik, and M. Hajduch, “Aurora kinase inhibitors: progress towards the clinic,” Investigational New Drugs, vol. 30, no. 6, pp. 2411–2432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Dennis, M. Davies, S. Oliver, R. D'Souza, L. Pike, and P. Stockman, “Phase i study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia,” Cancer Chemotherapy and Pharmacology, vol. 70, no. 3, pp. 461–469, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. R. W. Wilkinson, R. Odedra, S. P. Heaton et al., “AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis,” Clinical Cancer Research, vol. 13, no. 12, pp. 3682–3688, 2007. View at Publisher · View at Google Scholar · View at Scopus